Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115,244,363
-
Total 13F shares
-
29,504,529
-
Share change
-
-1,072,295
-
Total reported value
-
$2,576,514,956
-
Put/Call ratio
-
51%
-
Price per share
-
$87.31
-
Number of holders
-
259
-
Value change
-
-$50,016,530
-
Number of buys
-
119
-
Number of sells
-
113
Institutional Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q4 2025
As of 31 Dec 2025,
GLOBUS MEDICAL INC - Class A Stock (GMED) was held by
259 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,504,529 shares.
The largest 10 holders included
VANGUARD GROUP INC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, Boston Trust Walden Corp, NORGES BANK, ANTIPODES PARTNERS Ltd, Artemis Investment Management LLP, Stephens Investment Management Group LLC, Swedbank AB, and Paradice Investment Management LLC.
This page lists
261
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.